×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OMCL – omnicell, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OMCL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/1
04:01 pm
omcl
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show
Medium
Report
Omnicell to Host Innovation Update and Q&A Session at Upcoming ASHP Midyear Industry Trade Show
11/29
09:55 am
omcl
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) [Yahoo! Finance]
Low
Report
A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL) [Yahoo! Finance]
11/20
04:30 pm
omcl
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Medium
Report
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/20
04:01 pm
omcl
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
Omnicell to Present at the Piper Sandler 37th Annual Healthcare Conference
11/13
08:17 am
omcl
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies [Yahoo! Finance]
Medium
Report
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies [Yahoo! Finance]
11/13
08:00 am
omcl
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies
Medium
Report
Omnicell Achieves URAC Certification, Strengthening Compliance and Scalability for Health System-Owned Specialty Pharmacies
11/13
04:46 am
omcl
Omnicell (OMCL): Rebound Sparks Fresh Look at Valuation and Growth Prospects [Yahoo! Finance]
Medium
Report
Omnicell (OMCL): Rebound Sparks Fresh Look at Valuation and Growth Prospects [Yahoo! Finance]
10/31
10:27 am
omcl
Omnicell (NASDAQ:OMCL) had its price target raised by analysts at Benchmark Co. from $40.00 to $45.00. They now have a "buy" rating on the stock.
Low
Report
Omnicell (NASDAQ:OMCL) had its price target raised by analysts at Benchmark Co. from $40.00 to $45.00. They now have a "buy" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
12/3
04:40 pm
omcl
Form 144 OMNICELL, INC. Filed by: Manley Corey J
Low
Report
Form 144 OMNICELL, INC. Filed by: Manley Corey J
12/3
04:05 pm
omcl
Form 4 OMNICELL, INC. For: Dec 01 Filed by: LIPPS RANDALL A
Low
Report
Form 4 OMNICELL, INC. For: Dec 01 Filed by: LIPPS RANDALL A
12/1
01:13 pm
omcl
Form 144 OMNICELL, INC. Filed by: LIPPS RANDALL A
Low
Report
Form 144 OMNICELL, INC. Filed by: LIPPS RANDALL A
11/18
04:23 pm
omcl
Form 4 OMNICELL, INC. For: Nov 15 Filed by: NUTT BRIAN H.
Low
Report
Form 4 OMNICELL, INC. For: Nov 15 Filed by: NUTT BRIAN H.
11/18
04:22 pm
omcl
Form 4 OMNICELL, INC. For: Nov 15 Filed by: LIPPS RANDALL A
Low
Report
Form 4 OMNICELL, INC. For: Nov 15 Filed by: LIPPS RANDALL A
11/18
04:20 pm
omcl
Form 4 OMNICELL, INC. For: Nov 15 Filed by: Njoku Nnamdi
Low
Report
Form 4 OMNICELL, INC. For: Nov 15 Filed by: Njoku Nnamdi
11/18
04:18 pm
omcl
Form 4 OMNICELL, INC. For: Nov 15 Filed by: Radford Harlan Baird
Low
Report
Form 4 OMNICELL, INC. For: Nov 15 Filed by: Radford Harlan Baird
11/18
04:15 pm
omcl
Form 4 OMNICELL, INC. For: Nov 15 Filed by: Etta Nchacha
Low
Report
Form 4 OMNICELL, INC. For: Nov 15 Filed by: Etta Nchacha
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/28
Omnicell, Inc. (NASDAQ: OMCL) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating.
12.2%
7/15 Omnicell Sets the Record Straight on GlassHouse Research Report 10.8%
7/25 Omnicell Reports Results for Second Quarter 2019 7.0%
4/28 Omnicell to Release First Quarter 2020 Earnings Results on May 7, 2020 5.3%
11/21 Female-led team launches life changing medical bill management app designed to help patients understand, manage and pay all medical bills in one place. 4.7%
6/20 Omnicell, Inc. (NASDAQ: OMCL) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 4.7%
11/18 Form 8-K OMNICELL, Inc For: Nov 15 4.6%
4/7 Form DEF 14A OMNICELL, Inc For: May 26 4.6%
11/1 Form 10-Q OMNICELL, Inc For: Sep 30 3.6%
6/17 Form 4 OMNICELL, Inc For: Jun 15 Filed by: LIPPS RANDALL A 3.1%
7/15 Omnicell Sets the Record Straight on GlassHouse Research Report 10.8%
7/25 Omnicell Reports Results for Second Quarter 2019 7.0%
4/28 Omnicell to Release First Quarter 2020 Earnings Results on May 7, 2020 5.3%
11/21 Female-led team launches life changing medical bill management app designed to help patients understand, manage and pay all medical bills in one place. 4.7%
6/20 Omnicell, Inc. (NASDAQ: OMCL) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 4.7%
11/18 Form 8-K OMNICELL, Inc For: Nov 15 4.6%
4/7 Form DEF 14A OMNICELL, Inc For: May 26 4.6%
11/1 Form 10-Q OMNICELL, Inc For: Sep 30 3.6%
6/17 Form 4 OMNICELL, Inc For: Jun 15 Filed by: LIPPS RANDALL A 3.1%
TOP News Decliners
7/11
Glancy Prongay & Murray LLP Announces Investigation on Behalf of Omnicell, Inc. Investors (OMCL)
-9.7%
10/24 Q3/2019 9/30/2019 EPS 0.760 ZacksConsensus 0.520 ActVsEst 0.240 - Beat -6.2%
2/7 Omnicell, Inc. (NASDAQ: OMCL) had its price target raised by analysts at Dougherty & Co from $92.00 to $100.00. They now have a "buy" rating on the stock. -4.3%
11/15 Form 4 OMNICELL, Inc For: Nov 15 Filed by: Seidelmann Scott Peter -4.2%
7/11 This Medical Stock Has Popped 78%; A Short-Seller Calls It A Scam [Investor's Business Daily] -4.1%
7/15 Northern Arizona Healthcare and Omnicell Formalize Long-Term Partnership to Digitize, Automate Medication Management Processes -4.1%
2/26 Form 10-K OMNICELL, Inc For: Dec 31 -4.0%
10/21 Form 4 OMNICELL, Inc For: Oct 18 Filed by: LIPPS RANDALL A -3.6%
1/30 Omnicell to Release Fourth Quarter 2019 Earnings Results on February 6, 2020 -3.4%
5/22 Form S-8 OMNICELL, Inc -2.7%
10/24 Q3/2019 9/30/2019 EPS 0.760 ZacksConsensus 0.520 ActVsEst 0.240 - Beat -6.2%
2/7 Omnicell, Inc. (NASDAQ: OMCL) had its price target raised by analysts at Dougherty & Co from $92.00 to $100.00. They now have a "buy" rating on the stock. -4.3%
11/15 Form 4 OMNICELL, Inc For: Nov 15 Filed by: Seidelmann Scott Peter -4.2%
7/11 This Medical Stock Has Popped 78%; A Short-Seller Calls It A Scam [Investor's Business Daily] -4.1%
7/15 Northern Arizona Healthcare and Omnicell Formalize Long-Term Partnership to Digitize, Automate Medication Management Processes -4.1%
2/26 Form 10-K OMNICELL, Inc For: Dec 31 -4.0%
10/21 Form 4 OMNICELL, Inc For: Oct 18 Filed by: LIPPS RANDALL A -3.6%
1/30 Omnicell to Release Fourth Quarter 2019 Earnings Results on February 6, 2020 -3.4%
5/22 Form S-8 OMNICELL, Inc -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: